HARBOR CAPITAL ADVISORS, INC. United Therapeutics Corporation Transaction History

HARBOR CAPITAL ADVISORS, INC. portfolio value:

$89,000
portfolio value

HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:

-11.14%
quarter

United Therapeutics Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -49.17% -413 shares -109K $209.38 427
Q2 2022 share Decrease -0.24% -2 shares 47K $235.64 840
Q1 2022 share Increase 0.00% 842 shares 151K $179.41 842